SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

People have been hearing a lot about H5N1 bird flu -- or highly pathogenic avian influenza -- since a B.C. teen became the ...

The detection was made at the Wahiawa wastewater treatment plant. DOH continues to collect samples to be sure there is not a ...

President-elect Donald Trump’s nominee would oversee agencies that regulate food, vaccines and medicine and were instrumental ...

Valley fever cases are up almost 50% in Arizona in 2024. It's not contagious as a person has to be exposed to fungal spores ...

Explore the implications of Robert F. Kennedy Jr.'s controversial nomination by Donald Trump as Health Czar and Secretary of ...

Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

The Food and Drug Administration (FDA) is considering removing oral phenylephrine, a common ingredient in many ...